Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Inflammation ; 35(6): 1844-50, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22821380

ABSTRACT

The present study was designed to evaluate inflammatory changes in collapsed lungs during one-lung ventilation using the assistance of a bronchoscopic microsampling probe. Serial albumin and interleukin (IL)-8 concentrations in epithelial lining fluid (ELF) were measured in seven patients undergoing resection of lung tumors. The samples were taken after induction of anesthesia (baseline), 30 min after one-lung ventilation was started (point 2), just before resuming two-lung ventilation (point 3), and 30 min after two-lung ventilation was restarted (point 4). The albumin and IL-8 concentrations in ELF were significantly increased at point 2 and point 3, respectively, and remained to be high, compared to the baseline. The increase in IL-8 at point 3 was correlated with the interval of one-lung ventilation; however, none developed specific acute lung injury. These findings suggest that inflammatory changes can occur on the epithelium of a collapsed lung even in patients who underwent successful and standard thoracic surgery.


Subject(s)
Interleukin-8/metabolism , One-Lung Ventilation , Pulmonary Atelectasis/metabolism , Respiratory Mucosa/immunology , Thoracotomy , Aged , Albumins/metabolism , Female , Humans , Inflammation/immunology , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Lung/immunology , Lung Neoplasms/surgery , Male , Middle Aged , Pulmonary Atelectasis/immunology , Pulmonary Edema/immunology , Respiratory Mucosa/metabolism , Tumor Necrosis Factor-alpha/metabolism
2.
Intern Med ; 46(20): 1745-8, 2007.
Article in English | MEDLINE | ID: mdl-17938532

ABSTRACT

A case of esophageal cancer who suffered from tracheal stenosis at the tracheostomy after stent implantation is presented. The patient received a covered metallic tracheal stent to seal the esophago-respiratory fistulation. After six months, the tracheal retainer for his tracheostomy was difficult to insert into his trachea due to the growth of the cancer. Argon plasma coagulation (APC) has been successfully employed in the dilatation of tracheal stenosis at the tracheostomy. We herein describe the use of APC as an effective treatment for further palliative therapy of tracheal dilatation in order to treat tracheal stenosis by esophageal cancer after stent implantation.


Subject(s)
Airway Obstruction/therapy , Esophageal Neoplasms/complications , Esophagoscopy , Stents , Tracheal Stenosis/therapy , Tracheoesophageal Fistula/therapy , Airway Obstruction/etiology , Bronchoscopy , Dilatation , Humans , Male , Middle Aged , Neoplasm Invasiveness , Palliative Care , Trachea/pathology , Tracheal Stenosis/etiology , Tracheoesophageal Fistula/etiology
3.
Ther Apher Dial ; 11(2): 138-45, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17381535

ABSTRACT

Endotoxin-removal direct hemoperfusion column containing polymyxin B immobilized fibers (PMX-DHP) is an effective procedure for the treatment of sepsis-induced acute respiratory distress syndrome (ARDS). We investigated retrospectively the effects and appropriate timing of PMX-DHP induction for directly induced ARDS in 38 patients. PMX-DHP was carried out twice for two hours. Blood pressure, heart rate (HR) and PaO(2)/FIO(2) (PF) ratio, leukocytes, platelets, endotoxin, inflammatory cytokines and clusters of differentiated peripheral neutrophils and monocytes were measured before and after PMX-DHP. Acute Physiology and Chronic Health Evaluation (APACHE) II scores, Sequential Organ Failure Assessment (SOFA) scores and lung injury scores (LIS) were determined at the time of starting PMX-DHP. The underlying causes of ARDS were pneumonia in 29 patients and aspiration pneumonia in 9 patients. The patients were divided into Survivors (n = 21) and Nonsurvivors (n = 17). Mortality was 45% at 30 days after PMX-DHP. The APACHE II and SOFA scores and the LIS were not significantly different between the two groups. The time from the onset of ARDS to the start of PMX-DHP was significantly delayed between the two groups. PMX-DHP significantly improved the PF ratio, HR and systolic blood pressure in the Survivors compared to the Nonsurvivors. The function of active monocytes in the peripheral blood was significantly suppressed after PMX-DHP. This early induction of PMX-DHP is indicated for directly induced ARDS. In the Nonsurvivors, this delay could have led to undesirable responses to oxygenation and circulation after PMX-DHP.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Hemoperfusion/methods , Polymyxin B/therapeutic use , Respiratory Distress Syndrome/therapy , Sepsis/therapy , APACHE , Aged , Chromatography , Endotoxins/blood , Female , Humans , Male , Multiple Organ Failure , Respiratory Distress Syndrome/mortality , Retrospective Studies , Survival Rate , Treatment Outcome
4.
Am J Ind Med ; 49(10): 826-35, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16948148

ABSTRACT

BACKGROUND: Bunashimeji-related hypersensitivity pneumonitis is found among workers who cultivate the mushroom in indoor facilities. An evaluation of protective measures was initiated using the outcomes of clinical, immunological, and radiological findings. METHODS: Twenty-two patients presented with symptoms of HP; all were employed cultivating Bunashimeji mushrooms in indoor facilities. After hospitalization, 6 of 22 patients quit their job to avoid exposure to spores (Avoidance group). Sixteen patients continued to work used a mask for 3 months, and were then divided into two subgroups: Mask alone (seven patients) and mask plus oral prednisolone (Mask + PSL) (nine patients). The erythrocyte sedimentation rate (ESR), serum Krebs von der Lungen-6 (KL-6), surfactant protein-D (SP-D), lymphocyte stimulation test (LST), ground-glass scores in chest high-resolution computed tomography (HRCT), and bronchoalveolar lavage (BAL) were assessed before and after treatment. RESULTS: Complete avoidance resulted in a significant decrease in LST. There was a significant decrease after PSL treatment in serum KL-6, SP-D, and total cell counts in the BAL fluid in the Mask + PSL group. In the Mask alone group, serum KL-6, SP-D, ground-glass scores in chest HRCT and total cell counts in BAL fluid showed high levels compared with the other two groups. CONCLUSIONS: Complete cessation was the best treatment for hypersensitivity pneumonitis. The use of a mask was ineffective for patients with a high serum KL-6 and SP-D concentration and severe ground-glass opacity on chest HRCT. Initial treatment with PSL is recommended for these patients with high levels of total cell counts in BAL fluid.


Subject(s)
Agaricales , Alveolitis, Extrinsic Allergic/prevention & control , Occupational Diseases/prevention & control , Agaricales/immunology , Aged , Alveolitis, Extrinsic Allergic/diagnostic imaging , Alveolitis, Extrinsic Allergic/immunology , Anti-Inflammatory Agents/therapeutic use , Antigens, Neoplasm/analysis , Blood Sedimentation , Bronchoalveolar Lavage Fluid/cytology , Cell Count , Female , Humans , Japan , Lung Volume Measurements , Lymphocyte Activation/immunology , Male , Masks , Middle Aged , Mucin-1 , Mucins/analysis , Occupational Diseases/diagnostic imaging , Occupational Diseases/immunology , Occupational Exposure , Prednisolone/therapeutic use , Pulmonary Surfactant-Associated Protein D/analysis , Spores , Tomography, X-Ray Computed
5.
Respirology ; 11(5): 659-62, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16916344

ABSTRACT

Post-intubation tracheal stenosis is usually caused by pressure necrosis at the cuff. Despite the fact that this phenomenon is well known and both large volume and low pressure cuffs have been developed, this lesion nevertheless continues to occur. Although the best results for tracheal reconstruction are obtained by an experienced surgeon, not all patients are able to undergo this operation for either medical or personal reasons. Argon plasma coagulation (APC) using flexible bronchoscopy has been successfully employed in the treatment of post-intubation tracheal stenosis in two of the surgery-refused and inoperable patients. The patients immediately experienced a relief of symptoms after APC. APC was thus performed 3-4 times every 1-2 weeks for each patient. In addition, there were no complications related to this procedure. The number of published clinical reports describing APC in benign airway stenosis are increasing. APC has also been reported to have several advantages over other interventional endobronchial techniques in the management of tracheo-bronchial stenosis. We report two patients, and to our knowledge this is the first description of APC being used in the treatment of endobronchial dilatation for post-intubation tracheal stenosis.


Subject(s)
Bronchoscopy/methods , Electrocoagulation/methods , Intubation, Intratracheal/adverse effects , Tracheal Stenosis/surgery , Aged , Argon/therapeutic use , Female , Humans , Tracheal Stenosis/etiology
6.
Respir Med ; 100(8): 1360-7, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16403614

ABSTRACT

This study was to examine the clinical differences between Stage 0 and normal subjects, using low-dose chest computed tomography (CT) and pulmonary function tests. Enrolled subjects performed as a health check for lung cancer screening including low-dose CT and pulmonary function tests. Subjects were divided into Stage 0, chronic obstructive pulmonary disease according to pulmonary function tests, and normal subjects. The severity of emphysema (visual score) was calculated on three low-dose CT slices. Low-dose CT and pulmonary function tests were performed in 1359 men and 888 women. The numbers and percentages of men and women smokers were 1076 (79.2%), and 107 (12.0%), respectively. A total of 722 individuals had one or more respiratory symptoms, such as cough (69.8%), sputum (75.8%), or shortness of breathing (0.83%). Of the 722 subjects, 71 (9.8%) individuals satisfied the criteria of chronic respiratory symptoms. Among the normal subjects, smoking caused differences in airflow limitation as a result of pulmonary function tests. The proportion of smokers and the visual score were significantly higher in Stage 0 than those in the normal subjects. The percentages of the maximal mid-expiratory flow (%MMF) and of the peak expiratory flow rate were significantly lower in Stage 0 than in the normal subjects. %MMF and the proportion of visual score were significantly lower in the smoking Stage 0 than in the nonsmoking Stage 0 subjects. Smoking would indicate early signs of emphysematous change between Stage 0 and normal subjects in comparison of pulmonary function tests and visual score of low-dose CT.


Subject(s)
Pulmonary Disease, Chronic Obstructive/diagnostic imaging , Female , Humans , Japan , Male , Mass Screening/methods , Middle Aged , Pulmonary Emphysema/diagnostic imaging , Respiratory Function Tests , Smoking/epidemiology , Tomography, X-Ray Computed
7.
Nephrology (Carlton) ; 10(3): 321-4, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15958050

ABSTRACT

A 57-year-old man was admitted to hospital because of motor aphasia on 16 September 2000. He had an approximate 2-year history of haemodialysis treatment, since April 1997, and had received a cadaveric renal transplantation in July 1999. Computed tomography and magnetic resonance imaging (MRI) revealed a mass with ringed enhancement in the left temporal-parietal lobe. Primary central nervous system (CNS) lymphoma (diffuse large B cell type) was diagnosed based on an open brain tumour biopsy. Epstein-Barr virus early RNA (EBER) in situ hybridization showed positive signals in the nuclei of the CNS lymphoma cells. A dose reduction of immunosuppressant and three series of high-dose methotrexate (MTX) therapy with leucovorine rescue followed by irradiation (whole brain irradiation, 30 Gy; partial brain tumour irradiation, 20 Gy) were carried out for his primary CNS lymphoma. The patient is currently in good condition (September 2004) with no enlargement of the lymphoma, as examined by MRI every 3 months, and preserved renal function.


Subject(s)
Antimetabolites, Antineoplastic/administration & dosage , Brain Neoplasms/drug therapy , Epstein-Barr Virus Infections/complications , Kidney Transplantation , Lymphoma, Large B-Cell, Diffuse/drug therapy , Methotrexate/administration & dosage , Aged , Brain Neoplasms/radiotherapy , Brain Neoplasms/virology , Cadaver , Combined Modality Therapy , Humans , Lymphoma, Large B-Cell, Diffuse/radiotherapy , Lymphoma, Large B-Cell, Diffuse/virology , Male , Postoperative Complications/drug therapy , Postoperative Complications/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL